SWP
FLNA

Stratos Wealth Partners’s Filana Therapeutics FLNA Stock Holding History

Stratos Wealth Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,433
Closed -$281K – 1110
2020
Q3 		$281K Buy
+24,433
New +$110K 0.01% 810

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stratos Wealth Partners's FLNA Position: Q4 2020 in Review

Stratos Wealth Partners sold out of Filana Therapeutics (FLNA) in Q4 2020, closing a stake of 24,433 shares — an estimated $281K sold.

Stratos Wealth Partners first reported a position in FLNA in Q3 2020 and held it in 1 quarter. The position peaked at $281K in Q3 2020. 79 funds tracked by Wall St. Rank hold FLNA as of Q4 2020.

  • Stratos Wealth Partners reported no remaining Filana Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Stratos Wealth Partners sold 24,433 Filana Therapeutics shares in Q4 2020, an estimated $281K.
  • Stratos Wealth Partners first reported a position in Filana Therapeutics in Q3 2020 and held it in 1 quarter.
  • Stratos Wealth Partners's Filana Therapeutics position peaked at $281K in Q3 2020.
  • 79 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2020.

Based on Stratos Wealth Partners's 13F filing for Q4 2020, filed 29 Jan 2021.